share_log

Raymond James Initiates Coverage On Pacira BioSciences With Outperform Rating, Announces Price Target of $42

Raymond James Initiates Coverage On Pacira BioSciences With Outperform Rating, Announces Price Target of $42

雷蒙德·詹姆斯以跑贏大盤的評級發起對Pacira BioSciences的報道,宣佈目標股價爲42美元
Benzinga ·  2023/12/20 06:31

Raymond James analyst Gary Nachman initiates coverage on Pacira BioSciences (NASDAQ:PCRX) with a Outperform rating and announces Price Target of $42.

雷蒙德·詹姆斯分析師加里·納赫曼以跑贏大盤的評級啓動了對帕西拉生物科學(納斯達克股票代碼:PCRX)的報道,並宣佈目標股價爲42美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論